AMIT KUMAR - 12 Jan 2024 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Chief Executive Officer, Director
Signature
/s/ Amit Kumar
Issuer symbol
ANIX
Transactions as of
12 Jan 2024
Transactions value $
$0
Form type
4
Filing time
16 Jan 2024, 19:05:55 UTC
Previous filing
31 Jul 2023
Next filing
15 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +700K $0.00 700K 12 Jan 2024 Common Stock 700K $4.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024.